Omeros (OMER) Non-Current Debt (2010 - 2026)
Omeros (OMER) reported Non-Current Debt of $52.8 million for Q1 2026, down 40.37% on a YoY basis from $88.6 million in Q1 2025, and up 2.82% sequentially from $51.4 million in Q4 2025.
Omeros (OMER) Non-Current Debt (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Non-Current Debt data on file, last reported at $52.8 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt fell 40.37% year-over-year to $52.8 million; the trailing twelve-month figure through Mar 2026 stood at $52.8 million (down 40.37% YoY), and the FY2025 full-year result was $51.4 million, down 47.14% from the prior year.
- Non-Current Debt rose to $52.8 million in Q1 2026, from $51.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $314.8 million in Q3 2022 to a low of $51.4 million in Q4 2025.
- A 5-year average of $167.4 million and a median of $155.3 million in 2024 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt grew 0.58% in 2022 and plunged 58.51% in 2025, its largest moves.
- Tracing OMER's Non-Current Debt over 5 years: stood at $220.9 million in 2022, then advanced by 0.42% to $221.8 million in 2023, then slumped by 56.19% to $97.2 million in 2024, then tumbled by 47.14% to $51.4 million in 2025, then advanced by 2.82% to $52.8 million in 2026.
- Business Quant data shows OMER's Non-Current Debt at $52.8 million in Q1 2026, $51.4 million in Q4 2025, and $72.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 52.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.81 Mn |
| Dec 31, 2025 | 51.36 Mn |
| Sep 30, 2025 | 72.08 Mn |
| Jun 30, 2025 | 87.31 Mn |
| Mar 31, 2025 | 88.56 Mn |
| Dec 31, 2024 | 97.18 Mn |
| Sep 30, 2024 | 92.43 Mn |
| Jun 30, 2024 | 94.51 Mn |
| Mar 31, 2024 | 213.46 Mn |
| Sep 30, 2023 | 221.83 Mn |
| Jun 30, 2023 | 221.52 Mn |
| Mar 31, 2023 | 221.21 Mn |
| Dec 31, 2022 | 220.91 Mn |
| Sep 30, 2022 | 314.82 Mn |
| Jun 30, 2022 | 314.36 Mn |
| Mar 31, 2022 | 313.90 Mn |
| Dec 31, 2021 | 313.46 Mn |
| Sep 30, 2021 | 313.02 Mn |
| Jun 30, 2021 | 312.59 Mn |
| Mar 31, 2021 | 312.16 Mn |